Investor Relations

TM            NexgenRxTM health claims adjudication and related services to Canadian companies and their employees. Through the use of leading-edge technology, no-touch processes and comprehensive provider networks, NexgenRxTM assists companies in containing and predicting health benefit costs and improving the return on their investment in employee health benefits.

 TM NexgenRxTM Inc. was incorporated under the Business Corporations Act (Ontario) in 2003 by its founder and current President and Chief Executive Officer, Ronald C. Loucks.

On September 7, 2006, NexgenRxTM Inc. completed an Initial Public Offering, raising approximately $5.2 million, followed by the listing of the common shares of NexgenRxTM Inc. on the TSX-Venture Exchange on September 14, 2006, under the trading symbol NXG.

Contact Information

NexgenRx™   Inc.
Corporate Head Office
185 The West Mall, Suite 600
Toronto, ON M9C 5L5

Ronald C. Loucks
President and CEO
Local: 416-695-3393 x801
Fax: 647-722-2920

email : Ronald C. Loucks

 

Related Links:

SEDAR
TSX Venture Exchange